SummaryRMgm-5114
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene tagging |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 36006241 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | P. berghei ANKA 2.34 |
Other information parent line | P. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943). |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Brusini L, Brochet M |
Name Group/Department | Department of Microbiology and Molecular Medicine, Faculty of Medicine |
Name Institute | University of Geneva |
City | Geneva |
Country | Switzerland |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-5114 |
Principal name | AKiT2-tag |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | No |
top of page | |
Phenotype | |
Asexual blood stage | See below |
Gametocyte/Gamete | See below |
Fertilization and ookinete | see below |
Oocyst | Not tested |
Sporozoite | Not tested |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation PBANKA_0812300 and PBANKA_1362400: in complex with SKA2 PBANKA_0621300 - Apicomplexan Kinetochore protein 1 (AKiT1) AKit2 - AKiT6: PBANKA_1202800 (AKiT2); PBANKA_0612200 (AKiT3), PBANKA_1310500 (AKiT4), PBANKA_1243900 (AKiT5), PBANKA_0522000 (AKiT6) AKiT7-9: PBANKA_0612300 (AKiT7), PBANKA_0213200 (AKiT8), PBANKA_1307000 (AKiT9) AKiT10-11: PBANKA_0406000 (AKiT10), PBANKA_0803900 (AKiT11) From the paper: |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1202800 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_1004500 | ||||||||||||||||||||||||||
Gene product | conserved Plasmodium protein, unknown function | ||||||||||||||||||||||||||
Gene product: Alternative name | Apicomplexan Kinetochore protein 2, AKiT2 | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Name of the tag | HA, mScarlet or pCP | ||||||||||||||||||||||||||
Details of tagging | C-terminal | ||||||||||||||||||||||||||
Additional remarks: tagging | |||||||||||||||||||||||||||
Commercial source of tag-antibodies | |||||||||||||||||||||||||||
Type of plasmid/construct | (Linear) plasmid double cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | hdhfr/yfcu | ||||||||||||||||||||||||||
Promoter of the selectable marker | eef1a | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | For C-terminal tagging of P. berghei proteins by PbGEM technology, 3xHA and mScarlet-I tagging constructs were generated using phage recombineering in E. coli TSA strain with PlasmoGEM vectors (http://plasmogem.sanger.ac.uk/) using sequential recombineering and gateway steps as described previously (Pfander et al., 2011). For genes SKA2 and NUF2, the Zeocin-resistance/Phe-sensitivity cassette was introduced using oligonucleotides goi-recR1 x goi-recR2 for 3xHA tagging and goi mSc-F x goi mSc-R for mSc tagging vectors. Insertion of the GW cassette following gateway reaction was confirmed using primer pairs GW1 x goi-QCR1 and GW2 x goi-QCR2. For C-terminal tagging of P. berghei proteins by pCP, constructs were newly derived from pOB277 (Patzewitz et al., 2013) in order to target endogenous loci by allele replacement instead of insertion. Briefly a 588 bp fragment encompassing the coding sequence of 3xHA and DHFR flanked by KpnI and EcoRI was amplified from PbGEM plasmid GW-R6K-3xHA using primers MB1033 and MB1034 and replaced the corresponding fragment in pOB277 to generate pCP-3xHA. The coding sequence for mNG flanked by AvrII and SacII sites was purchased from GeneArt and inserted upstream to 3xHA to generate pCP-mNG-3xHA. Sequences comprising 500 ∼500 bp from the C-terminus of the coding sequence and ~500 bp from the immediate 3’ UTR for genes SKA1, SKA3 and AKiTs 1 - 9 were cloned into KpnI and AvrII sites upstream to the mNG coding sequence, along with a NotI linearisation site between the targeting sequences. | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |